Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox study for chronic exertional compartment syndrome of the lower leg
2025-524042-99-00Phase 3Authorised
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic Exertional Compartment Syndrome (CECS) comparing Botulinum toxin type A with Placebo saline injection (2 arms). Primary endpoint: Single Assessment Numeric Evaluation score. Planned start Oct 2026; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
Chronic Exertional Compartment Syndrome (CECS)
Beyond the preview
Go deeper on 2025-524042-99-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524042-99-00.